Literature DB >> 7770124

Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits.

P Uvebrant1, R Bauzienè.   

Abstract

Fifty children and adolescents with intractable epilepsy were treated with lamotrigine. Most of the children had other neuro-impairments, such as mental retardation, cerebral palsy and autism, added to their epilepsy. Five stopped lamotrigine treatment within four months because of side effects. In the 45 children who continued treatment for a mean of 14 months, five became seizure-free and in 16 the seizure frequency was reduced more than 30 percent. Absences and complex partial seizures responded best. In 24 of the 45 children, the parents reported an improvement in the mental state of their child, with better contact, longer attention span and improved alertness. In eight of 13 autistic children, the autistic symptoms decreased during lamotrigine treatment. This also occurred in children with an unchanged seizure situation, indicating a specific positive psychotropic effect of lamotrigine in mentally retarded and autistic children.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7770124     DOI: 10.1055/s-2008-1073041

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  28 in total

Review 1.  Pharmacological treatment of mood disturbances, aggression, and self-injury in persons with pervasive developmental disorders.

Authors:  B H King
Journal:  J Autism Dev Disord       Date:  2000-10

Review 2.  Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders.

Authors:  M G Aman; K S Langworthy
Journal:  J Autism Dev Disord       Date:  2000-10

Review 3.  Neuropsychological and behavioral effects of antiepilepsy drugs.

Authors:  David W Loring; Susan Marino; Kimford J Meador
Journal:  Neuropsychol Rev       Date:  2007-10-18       Impact factor: 7.444

Review 4.  Childhood epilepsy and autism spectrum disorders: psychiatric problems, phenotypic expression, and anticonvulsants.

Authors:  Sally J Robinson
Journal:  Neuropsychol Rev       Date:  2012-08-09       Impact factor: 7.444

Review 5.  The new antiepileptic drugs.

Authors:  R E Appleton
Journal:  Arch Dis Child       Date:  1996-09       Impact factor: 3.791

Review 6.  Safety review of adult clinical trial experience with lamotrigine.

Authors:  J Messenheimer; E L Mullens; L Giorgi; F Young
Journal:  Drug Saf       Date:  1998-04       Impact factor: 5.606

7.  Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders.

Authors:  Eric Hollander; William Chaplin; Latha Soorya; Stacey Wasserman; Sherry Novotny; Jade Rusoff; Nicole Feirsen; Lauren Pepa; Evdokia Anagnostou
Journal:  Neuropsychopharmacology       Date:  2009-12-09       Impact factor: 7.853

8.  Increased white matter gyral depth in dyslexia: implications for corticocortical connectivity.

Authors:  Manuel F Casanova; Ayman S El-Baz; Jay Giedd; Judith M Rumsey; Andrew E Switala
Journal:  J Autism Dev Disord       Date:  2009-07-16

9.  Low-frequency repetitive transcranial magnetic stimulation (rTMS) affects event-related potential measures of novelty processing in autism.

Authors:  Estate Sokhadze; Joshua Baruth; Allan Tasman; Mehreen Mansoor; Rajesh Ramaswamy; Lonnie Sears; Grace Mathai; Ayman El-Baz; Manuel F Casanova
Journal:  Appl Psychophysiol Biofeedback       Date:  2010-06

10.  Treatment of Lennox-Gastaut syndrome: overview and recent findings.

Authors:  Kenou van Rijckevorsel
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.